Condensed consolidated and combined statements of operations and comprehensive loss (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Operating expenses
Research and development	$ 5,323,015	$ 3,027,206	$ 11,753,749	$ 4,847,276
General and administrative	986,870	389,862	2,802,867	1,085,586
Total operating expenses	6,309,885	3,417,068	14,556,616	5,932,862
Other income (expenses)
Bank charges and financing costs	(2,455)	(1,643)	(458,651)	(5,246)
Change in fair value of derivative liabilities (Note 8)	29,388	24,871	957,818	972,757
Amortization and extinguishment of remaining discount on preferred shares upon conversion of preferred shares		(120,762)	(1,884,233)	(265,650)
Other income (expenses)	(1,350)	142,071	4,943	36,701
Total other income (expenses)	25,583	44,537	(1,380,123)	738,562
Net loss before income taxes	(6,284,302)	(3,372,531)	(15,936,739)	(5,194,300)
Income tax recovery	222	5,044	222	5,044
Net loss	(6,284,080)	(3,367,487)	(15,936,517)	(5,189,256)
Net loss per common stock - basic and diluted (Note 7)	$ (0.59)	$ (15.64)	$ (1.97)	$ (32.02)
Basic and diluted weighted average common stock outstanding (Note 7)	10,695,042	301,745	7,984,052	301,745
Comprehensive loss:
Net loss	(6,284,080)	(3,367,487)	(15,936,517)	(5,189,256)
Other comprehensive income - unrealized gain on available for sale securities	6,421		7,301
Comprehensive loss	$ (6,277,659)	$ (3,367,487)	$ (15,929,216)	$ (5,189,256)